Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE2V.L Regulatory News (E2V)

  • There is currently no data for E2V

Contract Win

20 Sep 2006 07:00

e2v technologies PLC20 September 2006 20 September 2006 e2v technologies PLC e2v secures contract win worth £6.2M e2v technologies, a specialist developer and manufacturer of high technology components and sub-systems, announces a key UK Ministry of Defence (MOD) multi-year contract win worth a total of £6.2M. The £6.2M UK MOD contract is for the development and evaluation of a new high power, high bandwidth microwave transmitter from the company's Electronic Tubebusiness. e2v will be the prime contractor for the project in a consortium,which includes the University of Strathclyde and TMD Technologies Ltd. Deliveries against the contract will be completed over a three-year period. Keith Attwood, Chief Executive of e2v said: "The award of this contract is the result of many years' work between e2v andthe UK MOD, and illustrates our continued growth and expertise in deliveringdefence solutions." For further information: e2v technologies plc Tel: 01245 493493Keith Attwood/Mike Hannantwww.e2v.com Gavin Anderson & Company Tel: 020 7554 1400Keith Brookbank/Fergus Wylie NOTES FOR EDITORSe2v technologies plce2v technologies delivers the radio frequency and sensing technology that enables some of the world's most innovative medical and science, aerospace and defence, and industrial and commercial systems. For the year ended 31 March2006, e2v achieved sales of £112.3m. It is listed on the London Stock Exchange(e2v.l). In July 2006 the e2v group increased its size through acquisition of a facilityin Grenoble France, effectively increasing the group's annual turnover to circa£180m. e2v is a leading developer and manufacturer of high-technology electronic components and subsystems, which it supplies into three core areas: *Medical & Science: Sensor technology includes imaging sensors for intra-oral and panoramic dental X-ray, mammography, life science applications and X-raymicroscopy. Electronic tubes are the enabling technology behind radiotherapy cancer treatments, microwave medical therapy and high-energy physics. *Aerospace & Defence: Sensor technology includes military surveillance, targeting and guidance, space-based imaging and astronomy and radar & electronicwarfare and roadband data converters and microprocessors for aerospace applications. Electronic tubes provide the enabling technology behind radars,electronic countermeasures (ECM), electronic warfare and satellite communications. *Commercial & Industrial: Sensor technology includes marine radars, industrialsafety sensors, automotive radars and alarms and thermal imaging cameras used by fire fighters, CCD and CMOS highresolution area scan cameras for industrial inspection. Electronic tubes provideenabling technology behind TV broadcast, satellite communications, marine radar and food & industrial processing. In 2006 e2v won a Queen's award for Enterprise, granted in the Innovation category, for its L3Vision(tm) imaging sensors and cameras used in aerospace, medical and scientific imaging systems. e2v has approximately 1,800 employees worldwide with 3 UK based manufacturing sites in Chelmsford, Lincoln and High Wycombe, and a facility in Grenoble, France. In addition e2v has sales offices in the UK, USA, Germany and France, as well as a network of distributors covering other key territories. Further information on e2v technologies plc is available from its website,www.e2v.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Nov 20123:17 pmRNSHolding(s) in Company
23rd Nov 201211:15 amRNSHolding(s) in Company
23rd Nov 201211:15 amRNSHolding(s) in Company
20th Nov 20124:45 pmRNSNotification of Major Interest in Shares
20th Nov 201210:40 amRNSHolding(s) in Company
19th Nov 20129:00 amRNSHolding(s) in Company
15th Nov 201210:25 amRNSTotal Voting Rights
12th Nov 20124:40 pmRNSSecond Price Monitoring Extn
12th Nov 20124:35 pmRNSPrice Monitoring Extension
12th Nov 20123:21 pmRNSHolding(s) in Company
12th Nov 201211:30 amRNSHolding(s) in Company
5th Nov 20127:00 amRNSHalf-year results for six months to 30 September
1st Nov 20123:59 pmRNSDirector/PDMR Shareholding
11th Oct 20127:00 amRNSPeriod End Update
2nd Oct 20122:30 pmRNSHolding(s) in Company
26th Sep 20125:00 pmRNSAdditional Listing Announcement - Amendment
25th Sep 201210:00 amRNSTotal Voting Rights
21st Sep 20124:49 pmRNSAdditional Listings Announcement
13th Sep 20124:49 pmRNSShare Buy-back Programme Update
25th Jul 201212:12 pmRNSAGM - notification of proxy votes
25th Jul 20127:00 amRNSInterim Management Statement
10th Jul 201212:30 pmRNSTotal Voting Rights
3rd Jul 20124:30 pmRNSAwards under Long Term Incentive Plan
29th Jun 201210:21 amRNSAwards under Deferred Bonus Plan
18th Jun 201211:15 amRNSTotal Voting Rights
24th May 20123:30 pmRNSBlock Listing Return
22nd May 20123:15 pmRNSTotal Voting Rights
22nd May 20123:15 pmRNSDirector/PDMR Shareholding
21st May 20129:42 amRNSFinal Dividend Timetable
21st May 20127:00 amRNSResults for the year ended 31 March 2012
16th May 20127:00 amRNSSale of non-core businesses
15th May 201210:30 amRNSTotal Voting Rights
19th Apr 20127:00 amRNSYear end trading update
1st Mar 201211:20 amRNSTotal Voting Rights
27th Feb 20122:36 pmRNSHolding(s) in Company
27th Feb 201212:39 pmRNSHolding(s) in Company
20th Feb 20127:00 amRNSMemorandum of Understanding with Rio Tinto
1st Feb 201210:45 amRNSTotal Voting Rights
30th Jan 20127:00 amRNSInterim Management Statement
5th Jan 20123:41 pmRNSTotal Voting Rights
22nd Dec 201110:56 amRNSTotal Voting Rights
19th Dec 20117:16 amRNSShare Buyback
1st Dec 20113:56 pmRNSTotal Voting Rights
18th Nov 201112:44 pmRNSDirector/PDMR Shareholding
14th Nov 20117:00 amRNSHalf Yearly Report
13th Oct 20117:00 amRNSPeriod end update
6th Oct 20115:57 pmRNSAnnouncement Released In Error
6th Oct 20115:20 pmRNSHolding(s) in Company
6th Oct 20115:15 pmRNSHolding(s) in Company
3rd Oct 201112:44 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.